Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital

Journal of the National Medical Association

Volumn 99, Issue 4, 2007, Pages 384-388

  Widjaja, David ^a   Yarlagadda, Suresh ^a   Singu, Bheema S ^a   Loganathan, Raghu S ^a   Blum, Steve ^a   Bloom, Alan ^a   Remy, Prospere ^a  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

African Americans; Hepatitis; Latinos

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AFRICAN AMERICAN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; CANCER SCREENING; CHRONIC HEPATITIS; CLINICAL FEATURE; FEMALE; HEALTH INSURANCE; HEPATITIS B; HEPATITIS B VIRUS; HISPANIC; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PILOT STUDY; PORTAL HYPERTENSION; PREDICTION; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; TREATMENT INDICATION; TREATMENT REFUSAL; URBAN AREA; URBAN POPULATION;

ADENINE; ADOLESCENT; ADULT; AFRICAN AMERICANS; FEMALE; HEPATITIS B, CHRONIC; HISPANIC AMERICANS; HOSPITALS, URBAN; HUMANS; INSURANCE COVERAGE; INTERFERONS; LAMIVUDINE; LIVER CIRRHOSIS; MALE; MASS SCREENING; MIDDLE AGED; NEW YORK CITY; PATIENT COMPLIANCE; PHOSPHONIC ACIDS; PILOT PROJECTS; REFUSAL TO TREAT; RISK FACTORS; URBAN HEALTH; UTILIZATION REVIEW;

EID: 34247263916     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Center for Disease Control and Prevention. Hepatitis, Viral, Type B. Health Information for International Travel. 2001-2002:91.
2. Coleman PJ, McQuillan GM, Moyer LA, et al. Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis. 1998;178:954-959.
3. McQuillan GM, Coleman PJ, Kruszon-Moran D, et al. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health. 1999;89:14-18.
4. Kim WR, Ishitani MB, Dickson ER. Rising Burden of Hepatitis B in the United States: should 'the other' virus be forgotten?. Hepatology. 2002;36(4):222A.
5. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology. 2004;39(2):476-483.
6. Lok AS, McMahon BJ. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology. 2001; 34(6):1225-1241.
7. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Eng J Med. 2002;347:168-174.
8. Lee CS, Sheu JC, Wang M, et al. Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma. Br J Surg. 1996;83:330-333.
9. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology. 1995; 22: 432-438.
10. Marrero JA, Su GL, Wei W, et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology. 2003;37:1114-1121.
11. Yim HJ, Lok ASF. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatology. 2006;43(2 suppl 1):S173-S181.
12. Estrada AL. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Rep. 2002; 117(suppl 1):S126-S134.
13. Zeldis JB, Jain S, Kuramoto IK, et al. Seroepidemiology of viral infections among intravenous drug users in northern California. West J Med. 1992; 156: 30-35.
14. Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AD, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users. Am J Epidemiol. 1995;142:331-341.
15. Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev. 1994;16:418-436.
16. Goldstein ST, Alter MJ, Williams IT, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis. 2002;185:713-719.
17. Colin JF, Cazals-Hatem D, Loriot MA, et al. Influence of Human Immunodeficiency Virus Infection on Chronic Hepatitis B in Homosexual Men. Hepatology. 1999;29(4):1306-1310.
18. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol. 2004;2:87-106.
19. Lok AS, McMahon BJ. Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: Update of recommendations. Hepatology. 2004;39(3):857-861.
20. Kim WR, Benson JT, Therneau TM, et al. Changing Epidemiology of Hepatitis B in a U.S. Community. Hepatology. 2004;39(3):811-816.
21. Bang CT, Sargious TN, Widjaja D, et al. Recent epidemiology of chronic hepatitis B infection in lower Manhattan [abstract]. Gastroenterology. 2004;126(4-S2):A709.
22. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-1745.
23. Wai CT, Mak B, Chua W, et al. The majority of hepatitis B carriers are not on regular surveillance in Singapore. Singapore Med J. 2004;45(9):423-426.
24. Alegria M, Cao Z, McGuire TG, et al. Health insurance coverage for vulnerable populations:contrasting Asian Americans and Latinos in the United States. Inquiry. 2006;43(3):231-254.
25. McMahon BJ. Selecting appropriate management strategies for chronic hepatitis B: who to treat. Am J Gastroenterol. 2006;101:S7-S12.
26. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65-73.
27. Keeffe EB, Lok A, McMahon B, et al. Serum HBV DNA level as a predictor of hepatocellular carcinoma (HCC). HBV Watch [newsletter]. February 2006.